ProCE Banner Activity

CE / CME

Tools of the Trade: Implementing New Guidelines for NVAF Management and Treatment in Primary Care

Video

Recent updates to guidelines regarding nonvalvular atrial fibrillation care could change how you manage patients. In this video module, 2 experts highlight key updates and discuss the importance of a multidisciplinary approach and reducing the risk of stroke.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: December 18, 2024

Expiration: December 17, 2025

Share

Faculty

Alpesh N. Amin

Alpesh N. Amin, MD, MBA, MACP, MHM, FRCP (Lond), FACC, FHFSA, CPE

Associate Dean for Clinical Transformation
UC Irvine Health
Chief, Division of Hospital Medicine & Palliative Medicine
Department of Medicine
Professor of Medicine, Business, Population & Public Health, Nursing Science, Pharmacy & Pharmaceutical Science, and Biomedical Engineering
University of California, Irvine
Irvine, California

Christopher B. Granger

Christopher B. Granger, MD

Professor of Medicine and of Nursing
Duke University
Durham, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Target Audience

This activity is designed for primary care HCPs involved in the care of patients with NVAF, including physicians, nurse practitioners, and physician associates. 

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Nonvalvular Atrial Fibrillation (NVAF).

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Interpret clinical evidence that supports changes to NVAF care represented in the 2023 ACC/AHA/ACCP/HRS guidelines

  • Implement the latest best practices for managing NVAF and providing high-quality care, according to the most recent guidelines from ACC/AHA/ACCP/HRS.

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Alpesh N. Amin, MD, MBA, MACP, MHM, FRCP (Lond), FACC, FHFSA, CPE

Associate Dean for Clinical Transformation
UC Irvine Health
Chief, Division of Hospital Medicine & Palliative Medicine
Department of Medicine
Professor of Medicine, Business, Population & Public Health, Nursing Science, Pharmacy & Pharmaceutical Science, and Biomedical Engineering
University of California, Irvine
Irvine, California

Alpesh N. Amin, MD, MBA, MACP, MHM, FRCP (Lond), FACC, FHFSA, CPE: consultant/advisor/speaker: Alexion, Aseptiscope, AstraZeneca, Bayer, Dexcom, Ferring, Gilead, GlaxoSmithKline, Lilly, Novo Nordisk, Pfizer, Renibus, Reprieve, Salix, Seres, Spero.

Christopher B. Granger, MD

Professor of Medicine and of Nursing
Duke University
Durham, North Carolina

Christopher B. Granger, MD: consultant/advisor/speaker: AbbVie, Abiomed, Alnylam, Anthos, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardionomic, Cadrenal, CeleCore, Hengrui, Janssen, Medtronic, Merck, Novo Nordisk, Novartis, Pfizer, Philips, REATA, Roche, Veralox; researcher: Alnylam, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Lilly, Novartis, Pfizer, Philips, Roche.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 18, 2024, through December 17, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Physician Associate Continuing Medical Education

AAPA CME Accreditation - AAPA

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until December 17, 2025. PAs should only claim credit commensurate with the extent of their participation.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.